MARGARET K OFFERMANN, M.D.
Osteopathic Medicine at Jesse Hill Jr Dr, Atlanta, GA
License number
Georgia 32627
Category
Osteopathic Medicine
Type
Medical Oncology
Address
Address
80 Jesse Hill Jr Dr SE, Atlanta, GA 30303
Phone
(404) 616-4307
Personal information
See more information about MARGARET K OFFERMANN at radaris.comName
Address
Phone
7935 Fawndale Way, Atlanta, GA 30350
7935 Fawndale Way, Atlanta, GA 30350
7935 Fawndale Way, Smyrna, GA 30080
Professional information
Margaret K Offermann, Atlanta GA
Specialties:
Internist
Address:
80 Jesse Hill Jr Dr Se, Atlanta, GA 30303
Education:
Medical College of Virginia - Doctor of Medicine
Dana-Farber Cancer Institute - Fellowship - Oncology (Internal Medicine)
Bernard Mitchell Hospital-University of Chicago Hospitals - Residency - Family Medicine
Dana-Farber Cancer Institute - Fellowship - Oncology (Internal Medicine)
Bernard Mitchell Hospital-University of Chicago Hospitals - Residency - Family Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Oncology (Internal Medicine)
Dr. Margaret K Offermann, Atlanta GA - MD (Doctor of Medicine)
Specialties:
Oncology, Medical Oncology
Address:
7935 Fawndale Way, Atlanta 30350
Certifications:
Internal Medicine, 1984, Medical Oncology, 1987
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
7935 Fawndale Way, Atlanta 30350
Emory University Hospital
1364 Clifton Rd North #East, Atlanta 30322
Grady Memorial Hospital
80 Jesse Hill Jr Dr South #East, Atlanta 30303
Emory University Hospital
1364 Clifton Rd North #East, Atlanta 30322
Grady Memorial Hospital
80 Jesse Hill Jr Dr South #East, Atlanta 30303
Education:
Medical School
Virginia Commonwealth University / Medical College of Virginia School of Medicine
Graduated: 1980
U Chicago Hosp
Dana Farber Canc Inst
Virginia Commonwealth University / Medical College of Virginia School of Medicine
Graduated: 1980
U Chicago Hosp
Dana Farber Canc Inst
Treatment For Atherosclerosis And Other Cardiovascular And Inflammatory Diseases
US Patent:
5783596, Jul 21, 1998
Filed:
Jun 7, 1995
Appl. No.:
8/477881
Inventors:
Russell M. Medford - Atlanta GA
Margaret K. Offermann - Atlanta GA
R. Wayne Alexander - Atlanta GA
Sampath Parthasarathy - Atlanta GA
Margaret K. Offermann - Atlanta GA
R. Wayne Alexander - Atlanta GA
Sampath Parthasarathy - Atlanta GA
Assignee:
Emory University - Atlanta GA
International Classification:
A61K 3140, A61K 3154, A61K 31265, A61K 31185
US Classification:
514423
Abstract:
Dithiocarboxylates, and in particular, dithiocarbamates, block the induced expression of the endothelial cell surface adhesion molecule VCAM-1, and are therefor useful in the treatment of cardiovascular disease, including atherosclerosis, post-angioplasty restenosis, coronary artery diseases, and angina, as well as noncardiovascular inflammatory diseases that are mediated by VCAM-1.
Treatment For Atherosclerosis And Other Cardiovascular And Inflammatory Diseases
US Patent:
5877203, Mar 2, 1999
Filed:
Oct 17, 1996
Appl. No.:
8/722438
Inventors:
Russell M. Medford - Atlanta GA
Margaret K. Offermann - Atlanta GA
R. Wayne Alexander - Atlanta GA
Margaret K. Offermann - Atlanta GA
R. Wayne Alexander - Atlanta GA
Assignee:
Emory University - Atlanta GA
International Classification:
A61K 3140, A61K 3116, A61K 3110, A61K 3155
US Classification:
514423
Abstract:
Dithiocarboxylates, and in particular, dithiocarbamates, block the induced expression of the endothelial cell surface adhesion molecule VCAM-1, and are therefor useful in the treatment of cardiovascular disease, including atherosclerosis, post-angioplasty restenosis, coronary artery diseases, and angina, as well as noncardiovascular inflammatory diseases that are mediated by VCAM-1.
Treatment For Atherosclerosis And Other Cardiovascular And Inflammatory Diseases
US Patent:
5821260, Oct 13, 1998
Filed:
Jun 7, 1995
Appl. No.:
8/485307
Inventors:
Russell M. Medford - Atlanta GA
Margaret K. Offermann - Atlanta GA
R. Wayne Alexander - Atlanta GA
Sampath Parthasarathy - Atlanta GA
Margaret K. Offermann - Atlanta GA
R. Wayne Alexander - Atlanta GA
Sampath Parthasarathy - Atlanta GA
Assignee:
Emory University - Atlanta GA
International Classification:
A61K 3140, A61K 3154, A61K 31265, A61K 31185
US Classification:
514423
Abstract:
Dithiocarboxylates, and in particular, dithiocarbamates, block the induced expression of the endothelial cell surface adhesion molecule VCAM-1, and are therefor useful in the treatment of cardiovascular disease, including atherosclerosis, post-angioplasty restenosis, coronary artery diseases, and angina, as well as noncardiovascular inflammatory diseases that are mediated by VCAM-1.
Treatment For Atherosclerosis And Other Cardiovascular And Inflammatory Diseases
US Patent:
5792787, Aug 11, 1998
Filed:
Jun 7, 1995
Appl. No.:
8/486239
Inventors:
Russell M. Medford - Atlanta GA
R. Wayne Alexander - Atlanta GA
Margaret K. Offermann - Atlanta GA
R. Wayne Alexander - Atlanta GA
Margaret K. Offermann - Atlanta GA
Assignee:
Emory University - Atlanta GA
International Classification:
A61K 31445, A61K 3140, A61K 31395
US Classification:
514423
Abstract:
Dithiocarboxylates, and in particular, dithiocarbamates, block the induced expression of the endothelial cell surface adhesion molecule VCAM-1, and are therefor useful in the treatment of cardiovascular disease, including atherosclerosis, post-angioplasty restenosis, coronary artery diseases, and angina, as well as noncardiovascular inflammatory diseases that are mediated by VCAM-1.
Treatment For Atherosclerosis And Other Cardiovascular And Inflammatory Diseases
US Patent:
5380747, Jan 10, 1995
Filed:
Oct 30, 1992
Appl. No.:
7/969934
Inventors:
Russell M. Medford - Atlanta GA
Margaret K. Offermann - Atlanta GA
R. Wayne Alexander - Atlanta GA
Margaret K. Offermann - Atlanta GA
R. Wayne Alexander - Atlanta GA
Assignee:
Emory University - Atlanta GA
International Classification:
A61K 3140, A61K 3127
US Classification:
514423
Abstract:
Dithiocarboxylates, and in particular, dithiocarbamates, block the induced expression of the endothelial cell surface adhesion molecule VCAM-1, and are therefor useful in the treatment of cardiovascular disease, including atherosclerosis, post-angioplasty restenosis, coronary artery diseases, and angina, as well as noncardiovascular inflammatory diseases that are mediated by VCAM-1.